Among patients with dermatomyositis (n = 53), antisynthetase syndrome (n = 27), and IMNM (n = 76), 11 (21%), 7 (26%), and 9 (12%) patients were seropositive for anti‐NT5C1A antibody, respectively (Table S2). This evidence concerns the gene NT5C1A and antisynthetase syndrome.